Acinetobacter baumannii: an emerging multidrug-resistant threat

References

• Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin. Microbiol. Rev.9(2), 148–165 (1996).
   PubMed Web of Science ®Google Scholar
• Murray CK, Hospenthal DR. Treatment of multidrug resistant Acinetobacter. Curr. Opin. Infect. Dis.18, 502–506 (2005).
   PubMed Web of Science ®Google Scholar
• Seifert H, Baginski R, Schulze A, Pulverer G. Antimicrobial susceptibility of Acinetobacter species. Antimicrob. Agents Chemother.37(4), 750–753 (1993).
   PubMed Web of Science ®Google Scholar
• Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.Nat. Rev. Microbiol.5(12), 939–951 (2007).
   PubMed Web of Science ®Google Scholar
• Richet H, Fournier PE. Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide. Infect. Control Hosp. Epidemiol.27(7), 645–646 (2006).
   PubMed Web of Science ®Google Scholar
• Waterer GW, Wunderink RG. Increasing threat of Gram-negative bacteria. Crit. Care Med.29(Suppl. 4), N75–N81 (2001).
   PubMed Web of Science ®Google Scholar
• Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol.55, 1619–1629 (2006).
   PubMed Web of Science ®Google Scholar
• Van Looveren M, Goossens H, Group AS. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin. Microbiol. Infect.10, 684–704 (2004).
   PubMed Web of Science ®Google Scholar
• Fournier PE, Vallenet D, Barbe V et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet.2(1), 62–72 (2006).
   Web of Science ®Google Scholar
• Rahal JJ, Urban C. Acinetobacter. Semin. Respir. Crit. Care Med.21(4), 341–348 (2000).
   PubMedGoogle Scholar
• Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin. Infect. Dis.42, 692–699 (2006).
   PubMed Web of Science ®Google Scholar
• Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? BMC Infect. Dis.6, 130–137 (2006).
   PubMed Web of Science ®Google Scholar
• Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin. Infect. Dis.43, S43–S48 (2006).
   PubMed Web of Science ®Google Scholar
• Denton M, Wilcox MH, Parnell P et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J. Hosp. Infect.56, 106–110 (2004).
   PubMed Web of Science ®Google Scholar
• Hansen S, Stamm-Balderiahn S, Zuschneid I et al. Closure of medical departments during nosocomial outbreaks: data from a systemic analysis of the literature. J. Hospital Infect.65, 348–353 (2007).
   PubMed Web of Science ®Google Scholar
• Mulin B, Talon D, Viel JF et al. Risk factors for nosocomical colonization with multiresistant Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis.14(7), 569–576 (1995).
   PubMed Web of Science ®Google Scholar
• Berlau J, Aucken H, Malnick H, Pitt T. Distribution of Acinetobacter species on skin of healthy humans. Eur. J. Clin. Microbiol. Infect. Dis.18, 179–183 (1999).
   PubMed Web of Science ®Google Scholar
• Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J. Clin. Microbiol.35(11), 2819–2825 (1997).
   PubMed Web of Science ®Google Scholar
• Zeana C, Larson E, Sahni J, Bayuga SJ, Wu F, Della-Latta P. The epidemiology of multidrug-resistant Acinetobacter baumannii: does the community represent a reservoir? Infect. Control Hosp. Epidemiol.24, 275–279 (2003).
   PubMed Web of Science ®Google Scholar
• Stephens C, Francis SJ, Abell V, DiPersio JR, Wells P. Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and long-term acute care hospital. Am. J. Infect. Control35, 212–215 (2007).
   PubMed Web of Science ®Google Scholar
• Dijkshoorn L, van Aken E, Shunburne L et al. Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals. Clin. Microbiol. Infect.11, 329–332 (2005).
   PubMed Web of Science ®Google Scholar
• Donskey CJ. Antibiotic regimens and intestinal colonization with antibiotic-resistant Gram-negative bacilli. Clin. Infect. Dis.43, S62–S69 (2006).
   PubMedGoogle Scholar
• Falagas ME, Karveli EA. The changing global epidemiology of Acinetobacter baumannii infections: a development with major public health implications. Clin. Microbiol. Infect.13, 117–119 (2007).
   PubMed Web of Science ®Google Scholar
• Paterson DL. Serious infections in the intensive care unit: Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis.43, S41–S42 (2006).
   Google Scholar
• Villari P, Iacuzio L, Vozzella EA, Bosco U. Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy. Am. J. Infect. Control27, 247–253 (1999).
   PubMed Web of Science ®Google Scholar
• Vila J. Mechanisms of antimicrobial resistance in Acinetobacter baumannii. Rev. Med. Microbiol.9(2), 87 (1998).
   Google Scholar
• Gombac F, Riccio ML, Rossolini GM et al. Molecular characterization of integrons in epidemiologically unrelated clinical isolates of Acinetobacter baumannii from Italian hospitals reveals a limited diversity of gene cassette arrays. Antimicrob. Agents Chemother.46(11), 3665–3668 (2002).
   PubMedGoogle Scholar
• Smith MG, Gianoulis TA, Pukatzki S et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Develop.21, 601–614 (2007).
   PubMed Web of Science ®Google Scholar
• Garrouste-Orgeas M, Marie O, Rouveau M, Villiers S, Arlet G, Schlemmer B. Secondary carriage with multi-resistant Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infections and mortality. J. Hosp. Infect.34, 279–289 (1996).
   PubMedGoogle Scholar
• Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother.51(10), 3471–3484 (2007).
   PubMed Web of Science ®Google Scholar
• Sunenshine RH, Wright M-O, Maragakis LL et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis.13(1), 97–103 (2007).
   PubMed Web of Science ®Google Scholar
• Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit. Care10(2), R48 (2006).
   PubMed Web of Science ®Google Scholar
• Mahgoub S, Ahmed J, Glatt AE. Completely resistant Acinetobacter baumannii strains. Infect. Control Hosp. Epidemiol.23, 477–479 (2002).
   PubMed Web of Science ®Google Scholar
• Gkrania-Klotsas E, Hershow RC. Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality. Clin. Infect. Dis.43, 1224–1225 (2006).
   PubMedGoogle Scholar
• Abbo A, Carmeli Y, Navon-Venezia S, Siegman-Igra Y, Schwaber MJ. Impact of multidrug-resistant Acinetobacter baumannii on clinical outcomes. Eur. J. Clin. Microbiol. Infect. Dis.26, 793–800 (2007).
   PubMed Web of Science ®Google Scholar
• Krcmery V L, Kalavsky E. Multidrug-resistant Acinetobacter baumannii. Emerg. Infect. Dis.13(6), 943–944 (2007).
   PubMedGoogle Scholar
• Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii. Am. J. Infect. Control30, 386–390 (2002).
   PubMedGoogle Scholar
• Chen H-P, Chen T-L, Lai C-H et al. Predictors of mortality in Acinetobacter baumannii bacteremia. J. Microbiol. Immunol. Infect.38, 127–136 (2005).
   PubMedGoogle Scholar
• Davis KA, Moran KA, McAllister CK, Gray PJ. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg. Infect. Dis.11(8), 1218–1224 (2005).
   PubMed Web of Science ®Google Scholar
• Cisneros JM, Reyes MJ, Pachon J et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin. Infect. Dis.22(6), 1026–1032 (1996).
   PubMed Web of Science ®Google Scholar
• Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii: clinical features, epidemiology and predictors of mortality. Medicine74(6), 340–349 (1995).
   PubMed Web of Science ®Google Scholar
• Poutanen SM, Louie M, Simor AE. Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults. Eur. J. Clin. Microbiol. Infect. Dis.16(10), 737–740 (1997).
   PubMedGoogle Scholar
• Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y. Multidrug-resistant Acinetobacter baumannii. Emerg. Infect. Dis.11(1), 22–28 (2005).
   PubMed Web of Science ®Google Scholar
• Longo B, Pantosti A, Luzzi I et al. An outbreak of Acinetobacter baumannii in an intensive care unit: epidemiological and molecular findings. J. Hosp. Infect.64(3), 303–305 (2006).
   PubMedGoogle Scholar
• Koeleman JGM, Stoof J, Van der Bijl MW, Vandenbroucke-Grauls CMJE, Savelkoul PHM. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J. Clin. Microbiol.39 (1), 8–13 (2001).
   PubMedGoogle Scholar
• Scott PT, Petersen K, Fishbain J et al.Acinetobacter baumannii infections among patients at military medical facilities treating injured U. S. service members, 2002–2004. MMWR Morb. Mortal. Wkly Rep.53(45), 1063–1066 (2004).
   PubMedGoogle Scholar
• Murray CK, Yun HC, Griffith ME, Hospenthal DR, Tong MJ. Acinetobacter infection: what was the true impact during the Vietnam conflict? Clin. Infect. Dis.43(3), 383–384 (2006).
   PubMedGoogle Scholar
• Griffith ME, Ceremuga JM, Ellis MW, Guymon CH, Hospenthal DR, Murray CK. Acinetobacter skin colonization of US Army soldiers. Infect. Control Hosp. Epidemiol.27(7), 659–661 (2006).
   PubMed Web of Science ®Google Scholar
• Scott P, Deve G, Srinivasan A et al. An outbreak of multidrug-resistant Acinetobacter baumannii–calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin. Infect. Dis.44(12), 1577–1584 (2007).
   PubMed Web of Science ®Google Scholar
• Leung W-S, Chu C-M, Tsang K-Y, Lo F-H, Lo K-F, Ho P-L. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest129, 102–109 (2006).
   PubMed Web of Science ®Google Scholar
• McDonald LC, Banerjee SN, Jarvis WR, System NNIS. Seasonal variation of Acinetobacter infections: 1987–1996. Clin. Infect. Dis.29, 1133–1137 (1999).
   PubMedGoogle Scholar
• Young DM, Parke D, Ornston LN. Opportunities for genetic investigation afforded by Acinetobacter baylyi, a nutritionally versatile bacterial species that is highly competent for natural transformation. Ann. Rev. Microbiol.59, 519–551 (2005).
   PubMedGoogle Scholar
• Nielsen KM, Smalla K, Van Elsas JD. Natural transformation of Acinetobacter sp. strain BD413 with cell lysates of Acinetobacter sp., Pseudomonas fluorescens, and Burkholderia cepacia in soil mirocosms. Appl. Environ. Microbiol.66(1), 206–212 (2000).
   PubMedGoogle Scholar
• Choi CH, Lee EY, Lee YC et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell. Microbiol.7(8), 1127–1138 (2005).
   PubMed Web of Science ®Google Scholar
• Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology149, 3473–3484 (2003).
   PubMed Web of Science ®Google Scholar
• Joly-Guillou M-L. Clinical impact and pathogenicity of Acinetobacter. Clin. Microbiol. Infect.11, 868–873 (2005).
   PubMed Web of Science ®Google Scholar
• Lee JC, Koerten H, Van den Broek P et al. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res. Microbiol.157, 360–366 (2006).
   PubMed Web of Science ®Google Scholar
• Dorsey CW, Tolmasky ME, Crosa JH, Actis LA. Genetic organization of an Acinetobacter baumannii chromosomal region harboring genes related to siderophore biosynthesis and transport. Microbiology149, 1227–1238 (2003).
   PubMedGoogle Scholar
• Braun G, Vidotto MC. Evaluation of adherence, hemagglutination, and presence of genes codifying for virulence factors of Acinetobacter baumannii causing urinary tract infection. Mem. Inst. Oswaldo Cruz99(8), 839–844 (2004).
   PubMedGoogle Scholar
• van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect. Immun.75(12), 5597–5608 (2007).
   PubMed Web of Science ®Google Scholar
• Joly-Guillou M-L, Wolff M, Pocidalo J-J, Walker F, Carbon C. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob. Agents Chemother.41(2), 345–351 (1997).
   PubMed Web of Science ®Google Scholar
• Landman D, Bratu S, Kochar S et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J. Antimicrob. Chemother.60, 78–82 (2007).
   PubMedGoogle Scholar
• Hoban DJ, Bouchillon SK, Dowzicky MJ. Antimicrobial susceptibility of extended-spectrum β-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial. Diagn. Microbiol. Infect. Dis.57, 423–428 (2007).
   PubMed Web of Science ®Google Scholar
• Falagas ME, Mourtzoukou EG, Polemis M, Vatopoulos AC; Greek System for Surveillance of Antimicrobial Resistance. Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalised patients in Greece and treatment implications. Clin. Microbiol. Infect.13, 816–819 (2007).
   PubMed Web of Science ®Google Scholar
• Corbella X, Montero A, Miquel P et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J. Clin. Microbiol.38(11), 4086–4095 (2000).
   PubMed Web of Science ®Google Scholar
• Del Mar Tomas M, Cartell M, Pertega S et al. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin. Microbiol. Infect.11, 540–546 (2005).
   PubMed Web of Science ®Google Scholar
• Wang H, Chen M; Group CNPRSS. Surveillance for antimicrobial resistance among clinical isolates of Gram-negative bacteria from intensive care unit patients in China, 1996 to 2002. Diagn. Microbiol. Infect. Dis.51, 201–208 (2005).
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Abramson MA, Beekmann SE et al. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J. Clin. Microbiol.45(10), 3352–3359 (2007).
   PubMed Web of Science ®Google Scholar
• Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect.12, 826–836 (2006).
   PubMed Web of Science ®Google Scholar
• Joly-Guillou ML, Vallee E, Bergogn-Berezin E, Philippon A. Distribution of β-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus. J. Antimicrob. Chemother.22, 597–604 (1988).
   PubMed Web of Science ®Google Scholar
• Lopez-Hernandez S, Alarcon T, Lopez-Brea M. Biochemical characterization of chromosomal cephalosporinases from isolates belonging to the Acinetobacter baumannii complex. Clin. Microbiol. Infect.7(4), 218–226 (2001).
   PubMedGoogle Scholar
• Blechschmidt B, Borneleit P, Kleber H-P. Purification and characterization of an extracellular β-lactamase produced by Acinetobacter calcoaceticus. J. Gen. Microbiol.138, 1197–1202 (1992).
   PubMedGoogle Scholar
• Perilli M, Felici A, Oratore A et al. Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrob. Agents Chemother.40(3), 715–719 (1996).
   PubMed Web of Science ®Google Scholar
• Bou G, Martinez-Beltran J. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother.44(2), 428–432 (2000).
   PubMed Web of Science ®Google Scholar
• Hujer KM, Hamza NS, Hujer AM et al. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: defining a unique family of class C enzymes. Antimicrob. Agents Chemother.49(7), 2941–2948 (2005).
   PubMed Web of Science ®Google Scholar
• Beceiro A, Perez-Llarena FJ, Perez A et al. Molecular characterization of the gene encoding a new AmpC β-lactamase in Acinetobacter baylyi. J. Antimicrob. Chemother.59, 996–1000 (2007).
   PubMedGoogle Scholar
• Corvec S, Caroff N, Espaze E, Giraudeau C, Drugeon H, Reynaud A. AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J. Antimicrob. Chemother.52(4), 629–635 (2003).
   PubMed Web of Science ®Google Scholar
• Segal H, Nelson EC, Elisha BG. Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob. Agents Chemother.48(2), 612–614 (2004).
   PubMed Web of Science ®Google Scholar
• Heritier C, Poirel L, Nordmann P. Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin. Microbiol. Infect.12, 123–130 (2006).
   PubMed Web of Science ®Google Scholar
• Segal H, Garny S, Elisha BG. Is ISAba-1 customized for Acinetobacter? FEMS Microbiol. Lett.243, 425–429 (2005).
   PubMed Web of Science ®Google Scholar
• Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis.43, S49–S56 (2006).
   PubMed Web of Science ®Google Scholar
• Endimiani A, Luzzaro F, Migliavacca R et al. Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum β-lactamase. Antimicrob. Agents Chemother.51(6), 2211–2214 (2007).
   PubMedGoogle Scholar
• Sechi L, Karadenizli A, Deriu A et al. PER-1 type β-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med. Sci. Monit.10(6), CR-180–CR-184 (2004).
   Google Scholar
• Naas T, Coignard B, Carbonnet A et al. VEB-1 extended-spectrum β-lactamase-producing Acinetobacter baumannii, France. Emerg. Infect. Dis.12(8), 1214–1222 (2006).
   PubMedGoogle Scholar
• Walther-Rasmussen, Hoiby N. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases. Can. J. Microbiol.50, 137–165 (2004).
   PubMedGoogle Scholar
• Naas T, Kernbaum S, Allali S, Nordmann P. Multidrug-resistant Acinetobacter baumannii, Russia. Emerg. Infect. Dis.13(4), 669–671 (2007).
   PubMedGoogle Scholar
• Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum β-lactamases in Acinetobacter baumannii in Belgium. J. Antimicrob. Chemother.58, 178–182 (2006).
   PubMed Web of Science ®Google Scholar
• Carbonne A, Nass T, Blanckaert K et al. Investigation of a nosocomial outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. J. Hosp. Infect.60, 14–18 (2005).
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev.18(4), 657–686 (2005).
   PubMed Web of Science ®Google Scholar
• Arduino SM, Roy PH, Jacoby GA, Orman BE, Pineiro SA, Centron D. blaCTX-M-2 is located in an unusual class I integron (In35) which includes Orf513. Antimicrob. Agents Chemother.46(7), 2303–2306 (2002).
   PubMed Web of Science ®Google Scholar
• Brown S, Amyes SGB. The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents. Clin. Microbiol. Infect.11, 326–328 (2005).
   PubMedGoogle Scholar
• Brown S, Amyes S. OXA β-lactamases in Acinetobacter: the story so far. J. Antimicrob. Chemother.57, 1–3 (2006).
   PubMed Web of Science ®Google Scholar
• Heritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother.49(8), 3198–3202 (2005).
   PubMed Web of Science ®Google Scholar
• Turton J, Ward M, Woodford N et al. The role of ISAba1 in expression of oxa carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett.258, 72–78 (2006).
   PubMed Web of Science ®Google Scholar
• Bou G, Cervero G, Dominguez MA, Quereda C, Martinez-Beltran J. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases. J. Clin. Microbiol.38(9), 3299–3305 (2000).
   PubMed Web of Science ®Google Scholar
• Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother.49(1), 202–208 (2005).
   PubMed Web of Science ®Google Scholar
• Woodford N, Ellington MJ, Coelho JM et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents27, 351–353 (2006).
   PubMed Web of Science ®Google Scholar
• Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother.45(2), 583–588 (2001).
   PubMed Web of Science ®Google Scholar
• Hujer KM, Hujer AM, Hulten EA et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter spp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob. Agents Chemother.50(12), 4114–4123 (2006).
   PubMed Web of Science ®Google Scholar
• Bogaerts P, Naas T, Wybo I et al. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. J. Clin. Microbiol.44(11), 4189–4192 (2006).
   PubMed Web of Science ®Google Scholar
• Pournaras S, Markogiannakis A, Ikonomidis A et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemases in an intensive care unit. J. Antimicrob. Chemother.57, 557–561 (2006).
   PubMed Web of Science ®Google Scholar
• Bertini A, Poirel L, Bernabeu S et al. Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother.51(7), 2324–2328 (2007).
   PubMed Web of Science ®Google Scholar
• Giordano A, Varesi P, Bertini A et al. Outbreak of Acinetobacter baumannii producing the carbapenem-hydrolyzing oxacillinase OXA-58 in Rome, Italy. Microb. Drug Resist.13(1), 37–43 (2007).
   PubMedGoogle Scholar
• Navia MM, Ruiz J, Vila J. Characterization of an integron carrying a new class D β-lactamase (OXA-37) in Acinetobacter baumannii. Microb. Drug Resist.8(4), 261–265 (2002).
   PubMedGoogle Scholar
• Brown S, Young HK, Amyes SGB. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin. Microbiol. Infect.11, 15–23 (2005).
   PubMed Web of Science ®Google Scholar
• Valenzuela JK, Thomas L, Partridge SR, van der Reijden T, Dijkshoorn L, Iredell J. Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii. J. Clin. Microbiol.45(2), 453–460 (2007).
   PubMed Web of Science ®Google Scholar
• Koh TH, Sng L-H, Wang GCY, Hsu L-Y, Zhao Y. IMP-4 and OXA β-lactamses in Acinetobacter baumannii from Singapore. J. Antimicrob. Chemother.59, 627–632 (2007).
   PubMedGoogle Scholar
• Zhou H, Pi B-R, Yang Q et al. Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba-1–blaOXA-23 genes in a Chinese hospital. J. Med. Microbiol.56, 1076–1080 (2007).
   PubMedGoogle Scholar
• Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P. Modes and modulations of antibiotic gene expression. Clin. Microbiol. Rev.20(1), 79–114 (2007).
   PubMed Web of Science ®Google Scholar
• Lee K, Yum JH, al el. Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother.49, 4485–4491 (2005).
   PubMed Web of Science ®Google Scholar
• Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev.18(2), 306–325 (2005).
   PubMed Web of Science ®Google Scholar
• Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States. Antimicrob. Agents Chemother.49(8), 3538–3540 (2005).
   PubMed Web of Science ®Google Scholar
• Toleman MA, Biedenbach D, Bennett DMC, Jones RN, Walsh TR. Italian metallo-β-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J. Antimicrob. Chemother.55, 61–70 (2005).
   PubMed Web of Science ®Google Scholar
• Hanson ND, Hossain A, Buck L, Moland ES, Thomson KS. First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-β-lactamase, IMP-18. Antimicrob. Agents Chemother.50(6), 2272–2273 (2006).
   PubMed Web of Science ®Google Scholar
• Wroblewska MM, Towner KJ, Marchel H, Luczak M. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clin. Microbiol. Infect.13, 490–496 (2007).
   PubMed Web of Science ®Google Scholar
• Ellington MJ, Kistler J, Livermore DM, Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-β-lactamases. J. Antimicrob. Chemother.59, 321–322 (2007).
   PubMed Web of Science ®Google Scholar
• Ying CM, Ling TKW, Lee CC, Ling JM. Characterization of carbapenem-resistant Acinetobacter baumannii in Shanghai and Hong Kong. J. Med. Microbiol.55(Pt 6), 799–802 (2006).
   PubMedGoogle Scholar
• Yong D, Choi YS, Roh KH et al. Increasing prevalence and diversity of metallo-β-lactamases in Pseudomonas spp. Acinetobacter spp. and Enterobacteriaceae from Korea. Antimicrob. Agents Chemother.50(5), 1884–1886 (2006).
   PubMed Web of Science ®Google Scholar
• Tsakris A, Ikonomidis A, Pournaras S et al. VIM-1 metallo-β-lactamase in Acinetobacter baumannii. Emerg. Infect. Dis.12(6), 981–983 (2006).
   PubMed Web of Science ®Google Scholar
• Noppe-Leclercq I, Wallet F, Haentjens S, Courcol R, Simonet M. PCR detection of aminoglycoside resistance genes: a rapid molecular typing method for Acinetobacter baumannii. Res. Microbiol.150, 317–322 (1999).
   PubMed Web of Science ®Google Scholar
• Huys G, Cnockaert M, Nemec A et al. Repetitive-DNA-element PCR fingerprinting and antibiotic resistance of pan-European multiresistant Acinetobacter baumannii clone III strains. J. Med. Microbiol.54, 851–856 (2005).
   PubMedGoogle Scholar
• Vila J, Marcos A, Marco F et al. In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother.37(1), 138–141 (1993).
   PubMed Web of Science ®Google Scholar
• Sato K, Nakae T. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J. Antimicrob. Chemother.28(1), 35–45 (1991).
   PubMed Web of Science ®Google Scholar
• Vila J, Marti S, Sanchez-Cespedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J. Antimicrob. Chemother.59, 1210–1215 (2007).
   PubMed Web of Science ®Google Scholar
• Gribun A, Nitzan Y, Pechatnikov I, Hershkovits G, Katcoff DJ. Molecular and structural characterization of the HMP-AB gene encoding a pore-forming protein from a clinical isolate of Acinetobacter baumannii. Curr. Microbiol.47(5), 434–443 (2003).
   PubMed Web of Science ®Google Scholar
• Siroy A, Molle V, Lemaitre-Guillier C et al. Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii. Antimicrob. Agents Chemother.49(12), 4876–4883 (2005).
   PubMed Web of Science ®Google Scholar
• Mussi MA, Limansky AS, Viale A. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins. Antimicrob. Agents Chemother.49(4), 1432–1440 (2005).
   PubMed Web of Science ®Google Scholar
• Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical islate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob. Agents Chemother.50(10), 3396–3406 (2006).
   PubMed Web of Science ®Google Scholar
• Limansky AS, Mussi MA, Viale AM. Loss of a 29-kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J. Clin. Microbiol.40(12), 4776–4778 (2002).
   PubMedGoogle Scholar
• Clark RB. Imipenem resistance among Acinetobacter baumannii: association with reduced expression of a 33–36 kDa outer membrane protein. J. Antimicrob. Chemother.38, 245–251 (1996).
   PubMed Web of Science ®Google Scholar
• Magnet S, Courvalin P, Lambert T. Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother.45(12), 3375–3380 (2001).
   PubMed Web of Science ®Google Scholar
• Marchand I, Damier-Piolle L, Courvalin P, Lambert T. Expression of the RND-type efflux pump AdeABD in Acinetobacter baumannii is regulated by the AdeRS two component system. Antimicrob. Agents Chemother.48(9), 3298–3304 (2004).
   PubMed Web of Science ®Google Scholar
• Piddock LJV. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev.19(2), 382–402 (2006).
   PubMed Web of Science ®Google Scholar
• Ruzin A, Keeney D, Bradford PA. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter alcoaceticus-Acinetobacter baumannii complex. J. Antimicrob. Chemother.59, 1001–1004 (2007).
   PubMed Web of Science ®Google Scholar
• Peleg AY, Adams J, Paterson DL. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob. Agents Chemother.51(6), 2065–2069 (2007).
   PubMed Web of Science ®Google Scholar
• Reid GE, Grim SA, Aldeza CA, Janda WM, Clark NM. Rapid development of Acinetobacter baumannii resistance to tigecycline. Pharmacotherapy27(8), 1198–1201 (2007).
   PubMed Web of Science ®Google Scholar
• Peleg AY, Potoski BA, Rea R et al.Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J. Antimicrob. Chemother.59, 128–131 (2007).
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug resistant Acinetobacter baumannii. J. Antimicrob. Chemother.59, 772–774 (2007).
   PubMed Web of Science ®Google Scholar
• Ribera A, Roca I, Ruiz J, Gibert I, Vila J. Partial characterization of a transposon containing the tet(A) determinant in a clinical isolate of Acinetobacter baumannii. J. Antimicrob. Chemother.52, 477–480 (2003).
   PubMedGoogle Scholar
• Wisplinghoff H, Decker M, Haefs C, Krut O, Plum G, Seifert H. Mutations in gyrA and parC associated with resistance to fluoroquinolones in epidemiologically defined clinical strains of Acinetobacter baumannii. J. Antimicrob. Chemother.51, 177–180 (2003).
   PubMedGoogle Scholar
• Munoz-Price LS, Weinstein R. Acinetobacter infection. N. Engl. J. Med.358, 1271–1281 (2008).
   PubMed Web of Science ®Google Scholar
• Bernabeu-Wittel M, Pichardo C, Garcia-Curiel A et al. Pharmacokinetic/pharmacodynamic assessment of the in vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia. Clin. Microbiol. Infect.11(4), 319–325 (2005).
   PubMed Web of Science ®Google Scholar
• Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin. Infect. Dis.43, S95–S99 (2006).
   PubMed Web of Science ®Google Scholar
• Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin. Infect. Dis.31, 101–106 (2000).
   PubMed Web of Science ®Google Scholar
• Rice LB. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin. Infect. Dis.43, S100–S105 (2006).
   PubMed Web of Science ®Google Scholar
• Linden PK, Paterson DL. Parenteral and inhaled colistin for treatment of ventilator-assocaited pneumonia. Clin. Infect. Dis.43, S89–S94 (2006).
   PubMed Web of Science ®Google Scholar
• Corbella X, Ariza J, Ardanuy C et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J. Antimicrob. Chemother.42, 793–802 (1998).
   PubMed Web of Science ®Google Scholar
• Urban C, Go E, Mariano N et al. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J. Infect. Dis.167, 448–451 (1993).
   PubMed Web of Science ®Google Scholar
• Antoniadou A, Kontopidou F, Poulakou G et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J. Antimicrob. Chemother.59, 786–790 (2007).
   PubMed Web of Science ®Google Scholar
• Hawley JS, Murray CK, Jorgensen JH. Development of colistin-dependent Acinetobacter baumannii–Acinetobacter calcoaceticus complex. Antimicrob. Agents Chemother.51(12), 4529–4530 (2007).
   PubMed Web of Science ®Google Scholar
• Urban C, Go E, Mariano N, Rahal JJ. Interaction of sulbactam, clavulanic acid and tazobactam with penicillin-binding proteins of imipenem-resistant and -susceptible Acinetobacter baumannii. FEMS Microbiol. Lett.125, 193–198 (1995).
   Web of Science ®Google Scholar
• Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systemic review of the evidence from old and recent studies. Crit. Care Med.10, R27 (2006).
   Google Scholar
• Harris AD, McGregor J, Furuno JP. What infection control interventions should be undertaken to control multidrug-resistant Gram-negative bacteria? Clin. Infect. Dis.43, S57–S61 (2006).
   PubMed Web of Science ®Google Scholar
• Fujitani S, Yu VL. Quantitative cultures for diagnosing ventilator-associated pneumonia: a critique. Clin. Infect. Dis.43, S106–S113 (2006).
   Google Scholar
• Segal H, Thomas R, Elisha BG. Characterization of class I integron resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii. Plasmid49, 169–178 (2003).
   PubMedGoogle Scholar
• Gu B, Tong M, Zhao W et al. Prevalence and characterization of class I integrons among Pseudomonas aeruginosa and Acinetobacter baumannii isolates from patients in Nanjing, China. J. Clin. Microbiol.45(1), 241–243 (2007).
   PubMed Web of Science ®Google Scholar
• Houang ETS, Chu Y-W, Lo W-S, Chu K-Y, Cheng AFB. Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-β-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000. Antimicrob. Agents Chemother.47(4), 1382–1390 (2003).
   PubMedGoogle Scholar
• Riccio ML, Franceschini N, Boschi L et al. Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob. Agents Chemother.44(5), 1229–1235 (2000).
   PubMed Web of Science ®Google Scholar
• Zarrilli R, Crispino M, Bagattini M et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J. Clin. Microbiol.42(3), 946–953 (2004).
   PubMed Web of Science ®Google Scholar
• Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, Ayala JA, Perea EJ, Pascual A. Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of cabapenems against clinical isolates of Acinetobacter baumannii. J. Antimicrob. Chemother.51, 565–574 (2003).
   PubMed Web of Science ®Google Scholar
• Beceiro A, Dominguez L, Ribera A et al. Molecular characterization of the gene encoding a new AmpC β-lactamase in a clinical strain of Acinetobacter genomic species 3. Antimicrob. Agents Chemother.48(4), 1374–1378 (2004).
   PubMedGoogle Scholar